These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10083305)

  • 1. Expression of human decay accelerating factor on cultured bone marrow cells from transgenic pigs.
    Ishida H; Richards AC; Cozzi E; White DJ
    Transplant Proc; 1999; 31(1-2):707-10. PubMed ID: 10083305
    [No Abstract]   [Full Text] [Related]  

  • 2. Endothelial cells from human decay acceleration factor transgenic pigs are protected against complement mediated tissue factor expression in vitro.
    Tucker AW; Carrington CA; Richards AC; Robson SC; White DJ
    Transplant Proc; 1997; 29(1-2):888. PubMed ID: 9123571
    [No Abstract]   [Full Text] [Related]  

  • 3. Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage.
    Byrne GW; McCurry KR; Martin MJ; McClellan SM; Platt JL; Logan JS
    Transplantation; 1997 Jan; 63(1):149-55. PubMed ID: 9000677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful generation of transgenic pigs for human decay-accelerating factor and human leucocyte antigen DQ.
    Tu CF; Hsieh SL; Lee JM; Yang LL; Sato T; Lee KH; Weng CN; Mao SJ; Tsuji K; Lee CJ
    Transplant Proc; 2000 Aug; 32(5):913-5. PubMed ID: 10936271
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination of decay-accelerating factor expression and alpha1,3-galactosyltransferase knockout affords added protection from human complement-mediated injury.
    van Denderen BJ; Salvaris E; Romanella M; Aminian A; Katerelos M; Tange MJ; Pearse MJ; d'Apice AJ
    Transplantation; 1997 Sep; 64(6):882-8. PubMed ID: 9326415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sperm-mediated gene transfer: production of pigs transgenic for a human regulator of complement activation.
    Lavitrano M; Forni M; Varzi V; Pucci L; Bacci ML; Di Stefano C; Fioretti D; Zoraqi G; Moioli B; Rossi M; Lazzereschi D; Stoppacciaro A; Seren E; Alfani D; Cortesini R; Frati L
    Transplant Proc; 1997 Dec; 29(8):3508-9. PubMed ID: 9414813
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined gene transfer of human decay accelerating factor and Bcl-XI provides protection to porcine xenograft endothelial cells.
    Cai CC; Chen S; Cheng DX; Guo H; Wang DW; Huang SX; Li JW; Wang H
    Transplant Proc; 2003 Feb; 35(1):521-2. PubMed ID: 12591513
    [No Abstract]   [Full Text] [Related]  

  • 8. Xenotransplantation of pig organs transgenic for human DAF: an update.
    Schmoeckel M; Bhatti FN; Zaidi A; Cozzi E; Pino-Chavez G; Dunning JJ; Wallwork J; White DJ
    Transplant Proc; 1997 Nov; 29(7):3157-8. PubMed ID: 9365707
    [No Abstract]   [Full Text] [Related]  

  • 9. Expression of complement regulatory proteins on islets of Langerhans: a comparison between human islets and islets isolated from normal and hDAF transgenic pigs.
    Bennet W; Björkland A; Sundberg B; Brandhorst D; Brendel MD; Richards A; White DJ; Nilsson B; Groth CG; Korsgren O
    Transplantation; 2001 Jul; 72(2):312-9. PubMed ID: 11477359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of pigs transgenic for human decay-accelerating factor.
    Cozzi E; Tucker AW; Langford GA; Pino-Chavez G; Wright L; O'Connell MJ; Young VJ; Lancaster R; McLaughlin M; Hunt K; Bordin MC; White DJ
    Transplantation; 1997 Nov; 64(10):1383-92. PubMed ID: 9392299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human decay accelerating factor transgenic pigs for xenotransplantation obtained by sperm-mediated gene transfer.
    Lavitrano M; Stoppacciaro A; Bacci ML; Forni M; Fioretti D; Pucci L; Di Stefano C; Lazzereschi D; Rughetti A; Ceretta S; Zannoni A; Rahimi H; Moioli B; Rossi M; Nuti M; Rossi G; Seren E; Alfani D; Cortesini R; Frati L
    Transplant Proc; 1999; 31(1-2):972-4. PubMed ID: 10083433
    [No Abstract]   [Full Text] [Related]  

  • 12. Production of transgenic pigs expressing human DAF (CD55) regulated by the porcine MCP gene promoter.
    Murakami H; Nagashima H; Takahagi Y; Fujimura T; Miyagawa S; Okabe M; Seya T; Shigehisa T; Taniguchi N; Shirakura R; Kinoshita T
    Transplant Proc; 2000 Nov; 32(7):2505-6. PubMed ID: 11120269
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel responses by transgenic pig endothelial cells to stimulation by human cytokines in terms of H-DAF, E-selectin and major histocompatibility complex class II expression.
    Carrington CA; Richards AC; Peters AL; White DJ
    Transplant Proc; 1997; 29(1-2):887. PubMed ID: 9123570
    [No Abstract]   [Full Text] [Related]  

  • 14. Transgenic pigs expressing both human decay-accelerating factor and N-acetylglucosaminyltransferase III.
    Takahagi Y; Miyagawa S; Murakami H; Matsunami K; Fujimura T; Shigehisa T; Shirakura R
    Transplant Proc; 2003 Feb; 35(1):516-7. PubMed ID: 12591510
    [No Abstract]   [Full Text] [Related]  

  • 15. Production of pigs transgenic for human DAF to overcome complement-mediated hyperacute xenograft rejection in man.
    White DJ; Yannoutsos N
    Res Immunol; 1996 Feb; 147(2):88-94. PubMed ID: 8792466
    [No Abstract]   [Full Text] [Related]  

  • 16. A synthetic dDAF (CD55) gene based on optimal codon usage for transgenic animals.
    Miyagawa S; Yamada M; Matsunami K; Koresawa Y; Ikawa M; Okabe M; Shirakura R
    J Biochem; 2001 May; 129(5):795-801. PubMed ID: 11328604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of human decay accelerating factor (hDAF) in transgenic pigs regulates complement activation during ex vivo liver perfusion--immunopathological findings.
    Pascher A; Poehlein C; Storck M; Abendroth D; Mueller-Hoecker J; Koenig W; Young VK; White DJ; Hammer C
    Transpl Int; 1996; 9 Suppl 1():S385-7. PubMed ID: 8959869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The function of transgenic human DAF-expressing porcine livers during hemoperfusion with human blood.
    Pöhlein C; Pascher A; Storck M; Young VK; König W; Abendroth D; Wick M; Thiery J; White DJ; Hammer C
    Transpl Int; 1996; 9 Suppl 1():S392-6. PubMed ID: 8959871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in transgenic pigs for xenotransplantation.
    Ascher NL
    Liver Transpl Surg; 1998 Mar; 4(2):180-1. PubMed ID: 9516573
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of cell surface concentration of human DAF on transgenic pig aortic endothelial cells on the degree of protection afforded against human complement deposition.
    Carrington CA; dos Santos Cruz G
    Xenotransplantation; 2001 May; 8(2):100-5. PubMed ID: 11328580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.